- Abstract:
-
BACKGROUND: The acute respiratory distress syndrome (ARDS) is a common cause of respiratory failure in critically ill patients. Experimental studies suggest that treatment with beta agonists may be helpful in ARDS. The Beta Agonist Lung Injury TrIal (BALTI-2) is a multicentre, pragmatic, randomised, double-blind, placebo-controlled clinical trial which aims to determine if sustained treatment with intravenous (IV) salbutamol will improve survival in ARDS. METHODS/DESIGN: Patients fulfilling t...
Expand abstract - Publication status:
- Published
- Journal:
- Trials
- Volume:
- 12
- Issue:
- 1
- Pages:
- 113
- Publication date:
- 2011-01-01
- DOI:
- EISSN:
-
1745-6215
- ISSN:
-
1745-6215
- URN:
-
uuid:70469cd1-e958-4bab-b959-889985270c6c
- Source identifiers:
-
155439
- Local pid:
- pubs:155439
- Language:
- English
- Keywords:
- Copyright date:
- 2011
Journal article
Beta Agonist Lung Injury TrIal-2 (BALTI-2) trial protocol: a randomised, double-blind, placebo-controlled of intravenous infusion of salbutamol in the acute respiratory distress syndrome.
Actions
Authors
Bibliographic Details
Item Description
Terms of use
Metrics
Altmetrics
Dimensions
If you are the owner of this record, you can report an update to it here: Report update to this record